Company: INTS
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001567264-25-000010
Chunk: 240

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 7A
Chunk 240
---
 the shares of Common Stock set forth opposite that person’s name. Unless indicated below, the address of each individual listed below is c/o Intensity Therapeutics Inc., 1 Enterprise Drive, Suite 430, Shelton, CT 06484-4779.

Name of Beneficial OwnerNumber of SharesBeneficially OwnedPercentage of SharesBeneficially OwnedDirectors and Executive OfficersLewis H. Bender(1)2,567,22716.3 %Joseph Talamo(2)105,476*John Wesolowski(3)97,822*Emer Leahy(4)116,500*Mark A. Goldberg(5)106,500*Daniel Donovan(6)43,750*Thomas I. H. Dubin(7)12,500*Directors and Executive Officers as a group (7 persons)(8)3,049,77518.8 %5% StockholdersLeonard Batterson(9)2,476,21316.3 %Armistice Capital, LLC(10)1,126,8687.4 %Craig J. Duchossois(11)1,062,7537.0 %* Less than 1%

(1)Includes 547,227 shares of Common Stock issuable upon the exercise of options that are exercisable within sixty days of March 1, 2025. Does not include 251,153 shares of Common Stock underlying options that are not exercisable within sixty days of March 1, 2025. 

(2)Includes 105,476 shares of Common Stock issuable upon the exercise of options that are exercisable within sixty days of March 1, 2025. Does not include 401,903 shares of Common Stock underlying options that are not exercisable within sixty days of March 1, 2025.  

(3)Includes 91,131 shares of Common Stock issuable upon the exercise of options that are exercisable within sixty days of March 1, 2025. Does not include 109,147 shares of Common Stock underlying options that are not exercisable within sixty days of March 1, 2025.  

(4)Includes 116,500 shares of Common Stock issuable upon the exercise of options that are exercisable within sixty days of March 1, 2025. Does not include 31,250 shares of Common Stock underlying options that are not exercisable within sixty days of March 1, 2025